News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,153 Results
Type
Article (87980)
Company Profile (825)
Press Release (781329)
Multimedia
Podcasts (196)
Webinars (28)
Section
Business (233268)
Career Advice (4147)
Deals (39883)
Drug Delivery (151)
Drug Development (91420)
Employer Resources (205)
FDA (18392)
Job Trends (17428)
News (397930)
Policy (39970)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3011)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (147)
Alliances (56981)
ALS (181)
Alzheimer's disease (1789)
Antibody-drug conjugate (ADC) (346)
Approvals (18574)
Artificial intelligence (626)
Autoimmune disease (161)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (201)
Biotechnology (490)
Bladder cancer (162)
Brain cancer (65)
Breast cancer (662)
Cancer (5031)
Cardiovascular disease (443)
Career advice (3570)
Career pathing (41)
CAR-T (303)
CDC (59)
Celiac Disease (1)
Cell therapy (825)
Cervical cancer (37)
Clinical research (77016)
Collaboration (1811)
Company closure (5)
Compensation (1152)
Complete response letters (70)
COVID-19 (2992)
CRISPR (99)
C-suite (860)
Cystic fibrosis (154)
Data (6260)
Decentralized trials (2)
Denatured (72)
Depression (150)
Diabetes (532)
Diagnostics (7226)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (302)
Drug pricing (223)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100140)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135067)
Executive appointments (1033)
FDA (21568)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1554)
Gene editing (215)
Generative AI (64)
Gene therapy (671)
GLP-1 (1125)
Government (5441)
Grass and pollen (8)
Guidances (385)
Healthcare (20945)
HIV (60)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (290)
Immuno-oncology (59)
Indications (97)
Infectious disease (3279)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (247)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (68)
Kidney cancer (17)
Labor market (93)
Layoffs (660)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (16)
Lung cancer (679)
Lymphoma (378)
Machine learning (45)
Management (66)
Manufacturing (850)
MASH (172)
Medical device (15027)
Medtech (15079)
Mergers & acquisitions (22985)
Metabolic disorders (1394)
Multiple sclerosis (161)
NASH (23)
Neurodegenerative disease (354)
Neuropsychiatric disorders (97)
Neuroscience (3105)
Neurotech (1)
NextGen: Class of 2026 (7708)
Non-profit (5112)
Now hiring (66)
Obesity (674)
Opinion (335)
Ovarian cancer (166)
Pain (209)
Pancreatic cancer (231)
Parkinson's disease (300)
Partnered (39)
Patents (508)
Patient recruitment (478)
Peanut (60)
People (66908)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23798)
Phase II (33419)
Phase III (25186)
Pipeline (5019)
Policy (336)
Postmarket research (3554)
Preclinical (10693)
Press Release (72)
Prostate cancer (246)
Psychedelics (54)
Radiopharmaceuticals (301)
Rare diseases (897)
Real estate (7439)
Recruiting (80)
Regulatory (29011)
Reports (67)
Research institute (2725)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (257)
Series B (197)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (113)
Tariffs (100)
The Weekly (122)
Vaccines (1147)
Venture capital (96)
Weight loss (462)
Women's health (87)
Worklife (21)
Date
Today (21)
Last 7 days (510)
Last 30 days (2427)
Last 365 days (32755)
2026 (2464)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (89)
Alaska (7)
Arizona (343)
Arkansas (14)
Asia (51559)
Australia (9055)
California (11522)
Canada (3308)
China (1164)
Colorado (488)
Connecticut (499)
Delaware (345)
Europe (118440)
Florida (1686)
Georgia (369)
Hawaii (4)
Idaho (68)
Illinois (963)
India (67)
Indiana (542)
Iowa (24)
Japan (428)
Kansas (133)
Kentucky (43)
Louisiana (29)
Maine (83)
Maryland (1456)
Massachusetts (8484)
Michigan (358)
Minnesota (664)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (86)
New Jersey (3103)
New Mexico (33)
New York (3043)
North Carolina (1609)
North Dakota (10)
Northern California (5510)
Ohio (354)
Oklahoma (22)
Oregon (54)
Pennsylvania (2307)
Puerto Rico (22)
Rhode Island (50)
South America (1661)
South Carolina (65)
South Dakota (1)
Southern California (4445)
Tennessee (176)
Texas (1817)
United States (41582)
Utah (346)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (970)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
There are 870,153 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Standard BioTools Completes Sale of SomaLogic to Illumina
February 1, 2026
·
6 min read
Press Releases
Jyong Biotech Subsidiary Announces Phase II Clinical Data on Cholesterol and LDH Indicators for MCS-8 (PCP), Indicating Potential in Prostate Cancer Prevention and Metabolic Value
February 1, 2026
·
5 min read
Press Releases
Ultragenyx Resubmits Biologics License Application for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) to U.S. FDA
February 1, 2026
·
8 min read
Press Releases
ALX Oncology Announces Pricing of Underwritten Offering - January 30, 2026
February 1, 2026
·
4 min read
Press Releases
Amplia Therapeutics - Quarterly Activities and Cash Flow Reports - December 2025
February 1, 2026
·
7 min read
Press Releases
Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)
February 1, 2026
·
11 min read
Press Releases
Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis
February 1, 2026
·
5 min read
Press Releases
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy
February 1, 2026
·
4 min read
Press Releases
ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
February 1, 2026
·
7 min read
Press Releases
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 30, 2026
February 1, 2026
·
3 min read
1 of 87,016
Next
